Dr. Mario Martínez Mingo

Mario Martínez Mingo obtained his BSc (2015) and MSc (2016) in Chemistry from the Universidad Autónoma de Madrid (UAM). He completed his PhD at the same university under the supervision of Prof. Juan Carlos Carretero and Dr. Nuria Rodríguez, focusing on the selective C–H bond functionalization via long-range metallacyclic intermediates stabilized by sulfur-containing coordinating groups. He subsequently joined Dr. Álvaro Somoza's group at IMDEA Nanoscience as a Juan de la Cierva researcher, where his work was centered on the synthesis and functionalization of nucleic acids for therapeutic applications. Currently, he is a researcher at IMDEA Nanoscience. His research now focuses on the development of targeted therapies based on aptamers for rare diseases, as well as the delivery of therapeutic oligonucleotides, including siRNA, antisense oligonucleotides (ASOs), plasmid DNA (pDNA), and mRNA, and the design of advanced nanosystems for biomedical applications.